Loading...
Pazopanib in the treatment of advanced renal cell carcinoma
Pazopanib is an orally available multitargeted tyrosine kinase inhibitor (a class of targeted therapies) that inhibits tumor angiogenesis and cell proliferation. The safety and efficacy of pazopanib (noninferior to sunitinib for progression-free survival) in patients with advanced or metastatic rena...
Na minha lista:
| Udgivet i: | Ther Adv Urol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4707425/ https://ncbi.nlm.nih.gov/pubmed/26834841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215614236 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|